Featured Articles
-
Future-Proofing Life Sciences Manufacturing: 2025 CDMO Trends
3/12/2025
Review contract manufacturing's evolution, driven by technological advancements and regulatory changes, and how CMOs and CDMOs are navigating opportunities and challenges.
-
Contract Manufacturing: Must-Know Trends And Strategies For 2025
2/12/2025
Regulated industries face rising demand, tech breakthroughs, and regulatory harmonization. Discover how contract manufacturers must leverage AI and cloud solutions to stay agile and compliant in the future.
-
Revolutionizing Contract Manufacturing With A Unified QMS And MES Platform
11/4/2024
Watch to gain expert insights on utilizing a closed-loop, single-platform approach and explore practical examples and data showcasing the advantages of integrating your QMS and MES.
-
6 Must-Haves For A Quality Management System (QMS)
9/20/2024
Not every quality management system (QMS) has the same capabilities and connectivity. Review several features to take into consideration when selecting a QMS system for your organization.
-
A Modern Pharma MES Solution Offers The Best Of Old And New
9/20/2024
What do legacy manufacturing execution systems (MESs) lack? What can a modern pharma MES solution do? Explore the advantages of using a modern MES to evaluate the efficiency of your production line.
-
Modernizing Your Cell & Gene Therapy Manufacturing Operations
9/29/2022
What requirements should cell and gene therapy developers meet to successfully bring innovative therapies to market?
-
A Guide To Writing Effective SOPs In Life Sciences
8/17/2022
We share some SOP guidelines that can help you build and manage documents that are easily accessible, relevant, and something your team can consistently rely upon.
-
The No. 1 Most Common Problem In FDA GMP Inspections
6/20/2022
With issues involving quality responsibilities and procedures at the top of the FDA warning list, we uncover where the solution to make this problem a thing of the past.
-
How To Avoid Pharma's Top 5 FDA Form 483 Triggers
10/13/2021
Explore the most commonly cited conditions that led to the issuance of Form 483s last year (summarized by the FDA's most recent 12-month inspection period) and tips for avoiding them.